TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 209 filers reported holding SAGE THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.20 and the average weighting 0.1%.

Quarter-by-quarter ownership
TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$433
-87.9%
21,020
-72.4%
0.00%
-88.6%
Q2 2023$3,577
+13.4%
76,089
+1.3%
0.04%
+9.4%
Q1 2023$3,153
+13.7%
75,137
+3.3%
0.03%
+10.3%
Q4 2022$2,774
-99.9%
72,737
-6.5%
0.03%
-19.4%
Q3 2022$3,045,000
-18.6%
77,768
-31.2%
0.04%0.0%
Q1 2022$3,740,000
-19.0%
113,001
+4.1%
0.04%
-12.2%
Q4 2021$4,619,000
+7.2%
108,587
+11.7%
0.04%
+2.5%
Q3 2021$4,308,000
+5.0%
97,214
+34.7%
0.04%
+5.3%
Q2 2021$4,101,000
-19.8%
72,190
+5.6%
0.04%
-24.0%
Q1 2021$5,116,000
-8.7%
68,347
+5.6%
0.05%
-10.7%
Q4 2020$5,602,000
+6414.0%
64,752
+4525.1%
0.06%
+5500.0%
Q3 2020$86,000
-97.3%
1,400
-93.9%
0.00%
-97.4%
Q3 2019$3,204,000
-30.5%
22,841
-9.3%
0.04%
-30.4%
Q2 2019$4,612,000
+15.1%
25,1900.0%0.06%
+12.0%
Q1 2019$4,006,000
+60.3%
25,190
-3.5%
0.05%
+47.1%
Q4 2018$2,499,000
-30.6%
26,092
+2.4%
0.03%
-20.9%
Q3 2018$3,599,000
-12.4%
25,480
-3.0%
0.04%
-12.2%
Q2 2018$4,110,000
-8.2%
26,260
-5.5%
0.05%
-9.3%
Q1 2018$4,477,000
-12.8%
27,794
-10.8%
0.05%
-10.0%
Q4 2017$5,135,000
+130.3%
31,176
-12.9%
0.06%
+122.2%
Q3 2017$2,230,000
-14.6%
35,793
+9.2%
0.03%
-18.2%
Q2 2017$2,610,00032,7760.03%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Finepoint Capital LP 475,600$15,362,0005.31%
Integral Health Asset Management, LLC 412,257$13,316,0002.74%
Palo Alto Investors LP 851,409$27,501,0002.40%
Boxer Capital, LLC 1,094,000$35,336,0002.24%
DAFNA Capital Management LLC 180,306$5,824,0001.59%
Ikarian Capital, LLC 250,000$8,075,0001.47%
Bellevue Group AG 2,973,178$96,034,0001.36%
SECTOR GAMMA AS 118,476$3,827,0000.86%
Artal Group S.A. 450,000$14,535,0000.78%
Diametric Capital, LP 19,393$626,0000.46%
View complete list of SAGE THERAPEUTICS INC shareholders